Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

1.

Reduced pulmonary surfactant interaction of daptomycin analogs via tryptophan replacement with alternative amino acids.

He Y, Li J, Yin N, Herradura PS, Martel L, Zhang Y, Pearson AL, Kulkarni V, Mascio C, Howland K, Silverman JA, Keith DD, Metcalf CA.

Bioorg Med Chem Lett. 2012 Oct 1;22(19):6248-51. doi: 10.1016/j.bmcl.2012.08.013. Epub 2012 Aug 9.

PMID:
22951041
[PubMed - indexed for MEDLINE]
2.

Genetically engineered lipopeptide antibiotics related to A54145 and daptomycin with improved properties.

Nguyen KT, He X, Alexander DC, Li C, Gu JQ, Mascio C, Van Praagh A, Mortin L, Chu M, Silverman JA, Brian P, Baltz RH.

Antimicrob Agents Chemother. 2010 Apr;54(4):1404-13. doi: 10.1128/AAC.01307-09. Epub 2010 Jan 19.

PMID:
20086142
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact.

Silverman JA, Mortin LI, Vanpraagh AD, Li T, Alder J.

J Infect Dis. 2005 Jun 15;191(12):2149-52. Epub 2005 May 5.

PMID:
15898002
[PubMed - indexed for MEDLINE]
Free Article
4.

Self-protecting bactericidal titanium alloy surface formed by covalent bonding of daptomycin bisphosphonates.

Chen CP, Wickstrom E.

Bioconjug Chem. 2010 Nov 17;21(11):1978-86. doi: 10.1021/bc100136e. Epub 2010 Oct 15.

PMID:
20949909
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Synthesis and biological activity of N-Acylated ornithine analogues of daptomycin.

Hill J, Siedlecki J, Parr I, Morytko M, Yu X, Zhang Y, Silverman J, Controneo N, Laganas V, Li T, Lai JJ, Keith D, Shimer G, Finn J.

Bioorg Med Chem Lett. 2003 Dec 1;13(23):4187-91.

PMID:
14622998
[PubMed - indexed for MEDLINE]
6.

An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus.

Patel JB, Jevitt LA, Hageman J, McDonald LC, Tenover FC.

Clin Infect Dis. 2006 Jun 1;42(11):1652-3. No abstract available.

PMID:
16652325
[PubMed - indexed for MEDLINE]
Free Article
7.

The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycin.

Sader HS, Jones RN.

Clin Infect Dis. 2006 Sep 15;43(6):798-9; author reply 799-800. No abstract available.

PMID:
16912964
[PubMed - indexed for MEDLINE]
Free Article
8.

In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey.

Arslan H, Azap OK, Ergin F, Karaman SO, OruƧ E.

Int J Antimicrob Agents. 2004 Jun;23(6):642-3. No abstract available.

PMID:
15194140
[PubMed - indexed for MEDLINE]
9.

Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions.

Moise PA, North D, Steenbergen JN, Sakoulas G.

Lancet Infect Dis. 2009 Oct;9(10):617-24. doi: 10.1016/S1473-3099(09)70200-2. Review.

PMID:
19778764
[PubMed - indexed for MEDLINE]
10.

Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus.

Hayden MK, Rezai K, Hayes RA, Lolans K, Quinn JP, Weinstein RA.

J Clin Microbiol. 2005 Oct;43(10):5285-7.

PMID:
16207998
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).

Saravolatz LD, Pawlak J, Johnson LB, Saravolatz LD 2nd, Husain N.

Int J Antimicrob Agents. 2010 Nov;36(5):478-80. doi: 10.1016/j.ijantimicag.2010.07.016. Epub 2010 Sep 16. No abstract available.

PMID:
20846830
[PubMed - indexed for MEDLINE]
12.

Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin.

Skiest DJ.

J Clin Microbiol. 2006 Feb;44(2):655-6.

PMID:
16455939
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates.

Anastasiou DM, Morgan M, Ruane PJ, Steenbergen JN, Katz BD, Alder JD, Thorne GM.

Diagn Microbiol Infect Dis. 2008 Jul;61(3):339-42. doi: 10.1016/j.diagmicrobio.2008.01.012. Epub 2008 Mar 4.

PMID:
18304772
[PubMed - indexed for MEDLINE]
14.

Structural characterization of daptomycin analogues A21978C1-3(d-Asn11) produced by a recombinant Streptomyces roseosporus strain.

Gu JQ, Nguyen KT, Gandhi C, Rajgarhia V, Baltz RH, Brian P, Chu M.

J Nat Prod. 2007 Feb;70(2):233-40. Epub 2007 Feb 7.

PMID:
17284073
[PubMed - indexed for MEDLINE]
15.

Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.

Pillai SK, Gold HS, Sakoulas G, Wennersten C, Moellering RC Jr, Eliopoulos GM.

Antimicrob Agents Chemother. 2007 Jun;51(6):2223-5. Epub 2007 Apr 2.

PMID:
17404001
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Activity of daptomycin against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae.

Sorlozano A, GutiƩrrez J, Roman J, Liebana J, Piedrola G.

Microb Drug Resist. 2009 Jun;15(2):125-7. doi: 10.1089/mdr.2009.0899.

PMID:
19432525
[PubMed - indexed for MEDLINE]
17.

Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.

Kelley PG, Gao W, Ward PB, Howden BP.

J Antimicrob Chemother. 2011 May;66(5):1057-60. doi: 10.1093/jac/dkr066. Epub 2011 Mar 2.

PMID:
21393156
[PubMed - indexed for MEDLINE]
Free Article
18.

Antimicrobial activity of daptomycin against Staphylococcus aureus isolates from skin and skin structure infections of trauma patients.

Behera B, Jain N, Sharma S, Mathur P, Misra MC.

J Infect. 2010 Jul;61(2):195-6. doi: 10.1016/j.jinf.2010.06.003. Epub 2010 Jun 12. No abstract available.

PMID:
20547179
[PubMed - indexed for MEDLINE]
19.

Effect of pulmonary surfactant on antimicrobial activity in vitro.

Schwameis R, Erdogan-Yildirim Z, Manafi M, Zeitlinger MA, Strommer S, Sauermann R.

Antimicrob Agents Chemother. 2013 Oct;57(10):5151-4. doi: 10.1128/AAC.00778-13. Epub 2013 Jul 22.

PMID:
23877678
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy.

Mariani PG, Sader HS, Jones RN.

J Antimicrob Chemother. 2006 Aug;58(2):481-3. No abstract available.

PMID:
16847029
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk